This finding suggests that overexpression of BUB1B may serve as a predictive marker for lung adenocarcinoma disease progression and provide a new potential targeting area for inhibiting metastasis and prolonging survival in lung adenocarcinoma patients. This evidence concerns the gene BUB1B and lung adenocarcinoma.